Binedaline

From Self-sufficiency
Revision as of 14:20, 29 July 2010 by PotatoBot (Talk) (Stub sorting and placement of stub template(s))

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Binedaline
File:Binedaline.png
Systematic (IUPAC) name
N,N,N-trimethyl-N-(3-phenylindol-1-yl)ethane-1,2-diamine
Clinical data
Routes of
administration
Oral
Legal status
Legal status
  • Uncontrolled
Identifiers
CAS Number 60662-16-0
ATC code none
PubChem CID 42509
ChemSpider 38769
Chemical data
Formula C19H24ClN3
Molar mass 329.86696 g/mol[[Script error: No such module "String".]]
Script error: No such module "collapsible list".
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Binedaline (Ixprim), also called binodaline, is a drug that was being investigated as an antidepressant in the 1980s but never marketed.[1][2] It acts as a selective norepinephrine reuptake inhibitor (Ki = 25 nM), with relatively insignificant influence on the serotonin (Ki = 847 nM) and dopamine (Ki >= 2 µM) transporters.[3] It has negligible affinity for the α-adrenergic, mACh, H1, or 5-HT2 receptors.[3]

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />



  1. Faltus; Geerling, FC (1984). "A controlled double-blind study comparing binedaline and imipramine in the treatment of endogenous depression". Neuropsychobiology. 12 (1): 34–8. doi:10.1159/000118107. PMID 6239991.  edit
  2. David J. Triggle (1996). Dictionary of Pharmacological Agents. Boca Raton: Chapman & Hall/CRC. ISBN 0-412-46630-9. 
  3. 3.0 3.1 Morin; Zini, R; Urien, S; Tillement, JP (1989). "Pharmacological profile of binedaline, a new antidepressant drug". The Journal of pharmacology and experimental therapeutics. 249 (1): 288–96. PMID 2540319.  edit